367 related articles for article (PubMed ID: 12830609)
21. Bisphosphonate treatment inhibits the growth of prostate cancer cells.
Lee MV; Fong EM; Singer FR; Guenette RS
Cancer Res; 2001 Mar; 61(6):2602-8. PubMed ID: 11289137
[TBL] [Abstract][Full Text] [Related]
22. FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation.
Ropiquet F; Giri D; Lamb DJ; Ittmann M
J Urol; 1999 Aug; 162(2):595-9. PubMed ID: 10411093
[TBL] [Abstract][Full Text] [Related]
23. Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion.
Scott LJ; Clarke NW; George NJ; Shanks JH; Testa NG; Lang SH
Br J Cancer; 2001 May; 84(10):1417-23. PubMed ID: 11355957
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia.
Castro P; Xia C; Gomez L; Lamb DJ; Ittmann M
Prostate; 2004 Jul; 60(2):153-9. PubMed ID: 15162381
[TBL] [Abstract][Full Text] [Related]
25. Utilization of the Boyden chamber to further characterize in vitro migration and invasion of benign and malignant human prostatic epithelial cells.
Fong CJ; Sutkowski DM; Kozlowski JM; Lee C
Invasion Metastasis; 1992; 12(5-6):264-74. PubMed ID: 1284346
[TBL] [Abstract][Full Text] [Related]
26. Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression.
Hobisch A; Fiechtl M; Sandahl-Sorensen B; Godoy-Tundidor S; Artner-Dworzak E; Ramoner R; Bartsch G; Culig Z
Prostate; 2004 Jun; 59(4):401-8. PubMed ID: 15065088
[TBL] [Abstract][Full Text] [Related]
27. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens.
Bright RK; Vocke CD; Emmert-Buck MR; Duray PH; Solomon D; Fetsch P; Rhim JS; Linehan WM; Topalian SL
Cancer Res; 1997 Mar; 57(5):995-1002. PubMed ID: 9041206
[TBL] [Abstract][Full Text] [Related]
28. In vitro modelling of epithelial and stromal interactions in non-malignant and malignant prostates.
Lang SH; Stower M; Maitland NJ
Br J Cancer; 2000 Feb; 82(4):990-7. PubMed ID: 10732776
[TBL] [Abstract][Full Text] [Related]
29. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
[TBL] [Abstract][Full Text] [Related]
30. Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence.
Xin H; Curry J; Johnstone RW; Nickoloff BJ; Choubey D
Oncogene; 2003 Jul; 22(31):4831-40. PubMed ID: 12894224
[TBL] [Abstract][Full Text] [Related]
31. Effect of nicotine on proliferation of normal, malignant, and human papillomavirus-transformed human cervical cells.
Waggoner SE; Wang X
Gynecol Oncol; 1994 Oct; 55(1):91-5. PubMed ID: 7959275
[TBL] [Abstract][Full Text] [Related]
32. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
[TBL] [Abstract][Full Text] [Related]
33. Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro.
Hedlund TE; van Bokhoven A; Johannes WU; Nordeen SK; Ogden LG
Prostate; 2006 Apr; 66(5):557-66. PubMed ID: 16372328
[TBL] [Abstract][Full Text] [Related]
34. Influence of suramin alone or in combination with DHT and PDGF on the cell proliferation of benign and malignant human prostatic tissues in organ cultures.
Michel P; Van Velthoven R; Petein M; Gras S; Etievant C; Pasteels JL; Kiss R
Anticancer Res; 1991; 11(6):2075-8. PubMed ID: 1723262
[TBL] [Abstract][Full Text] [Related]
35. [Prostate-specific antigen (PA) and deoxyribonucleic acid (DNA) analysis in prostatic epithelial cells using flow cytometry].
Shimabukuro T; Yoshihiro S; Matsuyama H; Yamamoto N; Sakatoku J
Hinyokika Kiyo; 1989 Aug; 35(8):1335-7. PubMed ID: 2479235
[TBL] [Abstract][Full Text] [Related]
36. Differentiation and stromal-induced growth promotion of murine prostatic tumors.
Salm SN; Takao T; Tsujimura A; Coetzee S; Moscatelli D; Wilson EL
Prostate; 2002 May; 51(3):175-88. PubMed ID: 11967952
[TBL] [Abstract][Full Text] [Related]
37. [Culturing of normal and tumor cells of the human prostate].
Cussenot O; Teillac P; Le Duc A; Ketels F; Calvo F
Ann Urol (Paris); 1989; 23(6):533-7. PubMed ID: 2482701
[TBL] [Abstract][Full Text] [Related]
38. Combined extracts of Urtica dioica and Pygeum africanum in the treatment of benign prostatic hyperplasia: double-blind comparison of two doses.
Krzeski T; Kazón M; Borkowski A; Witeska A; Kuczera J
Clin Ther; 1993; 15(6):1011-20. PubMed ID: 7509261
[TBL] [Abstract][Full Text] [Related]
39. Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells.
Zhang J; Hsu B A JC; Kinseth B A MA; Bjeldanes LF; Firestone GL
Cancer; 2003 Dec; 98(11):2511-20. PubMed ID: 14635088
[TBL] [Abstract][Full Text] [Related]
40. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo.
Srivastava SK; Xiao D; Lew KL; Hershberger P; Kokkinakis DM; Johnson CS; Trump DL; Singh SV
Carcinogenesis; 2003 Oct; 24(10):1665-70. PubMed ID: 12896904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
